BioSpace News Archive

Gerresheimer and Merck KGaA, Darmstadt, Germany, Transform Primary Packaging into Digital Twins

Gerresheimer AG and Merck KGaA, Darmstadt, Germany jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain.

October 27, 2022
·
2 min read
Drug Development

Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting

Kineta, Inc. announced that two abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer 37th Annual Meeting, to be held November 8-12, 2022 onsite in Boston, MA and online.

October 27, 2022
·
7 min read
Business

West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend

West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2022 and updated full-year 2022 financial guidance.

October 27, 2022
·
17 min read
Drug Development

Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy

Santhera Pharmaceuticals and ReveraGen BioPharma, Inc announce that they have completed the rolling submission of a new drug application to the U.S. Food and Drug Administration,seeking priority review for vamorolonefor the treatment of Duchenne muscular dystrophy.

October 27, 2022
·
6 min read
Genetown

Pandemic Protect Deployed in Massachusetts as COVID-19 Cases Rise

Quantgene, a medical intelligence firm specializing in precision medicine and advanced COVID-19 solutions, is now offering Pandemic Protect throughout Massachusetts as COVID-19 cases rise.

October 27, 2022
·
3 min read
Business

ONWARD Schedules Webcast to Provide Third Quarter 2022 Business Update and Announces Participation at Upcoming Conferences

ONWARD Medical N.V., the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, announced that it will host a webcast to discuss its Q3 business highlights.

October 27, 2022
·
5 min read
Business

Vitrolife AB (publ) Interim report Q3, 2022: Actions done and synergies ahead

Sales of SEK 798 (406) million, corresponding to an increase of 97% in SEK, whereof acquired growth 75% and currency effect 20%. Sales pro forma, adjusted for business related to Covid-19 tests, increased by 5% in local currencies.

October 27, 2022
·
2 min read
Business

Interim Report January - September 2022

Net sales amounted to SEK 96.8 million (54.9), corresponding to an increase of 76 percent in SEK and 57 percent adjusted for currency effects. Organic growth accounted for 35 percent and acquired growth for 22 percent.

October 27, 2022
·
5 min read
Policy

ITM Receives FDA Fast Track Designation for Radionuclide Therapy Candidate ITM-11 (n.c.a. 177Lu-edotreotide) in Neuroendocrine Tumors (GEP-NETs)

ITM Isotope Technologies Munich SE announced that the U.S. Food and Drug Administration has granted the company Fast Track designation for ITM-11, an investigational radiopharmaceutical for the treatment of gastroenteropancreatic neuroendocrine tumors.

October 27, 2022
·
4 min read
Pharm Country

Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa

Cambrex announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing.

October 27, 2022
·
2 min read